НАРУШЕНИЯ СЕКРЕЦИИ АНТИДИУРЕТИЧЕСКОГО ГОРМОНА
Ключевые слова:
антидиуретический гормон, секреция, нарушения, факторы, гомеостаз жидкости, электролитный баланс
Аннотация
Секреция антидиуретического гормона (АДГ) играет ключевую роль в поддержании водного баланса и регуляции осмотического равновесия в организме человека. Нарушения секреции АДГ могут иметь серьезные последствия для гомеостаза жидкости и приводить к возникновению различных клинических состояний. В данной статье предлагается всестороннее изучение сложных патофизиологических механизмов, клинических проявлений, методов диагностики и стратегий лечения, связанных с нарушениями секреции антидиуретического гормона. Кроме того, рассматриваются различные медицинские состояния и внешние факторы, которые могут влиять на секрецию АДГ, включая сахарный диабет, первичную полидипсию, стресс, употребление алкоголя, никотина и др. Глубокое понимание этих нарушений необходимо медицинским работникам для правильной диагностики пациентов и проведения соответствующих мероприятий, что в конечном итоге улучшает результаты лечения и повышает качество их жизни.
Скачивания
Данные скачивания пока недоступны.
Литература
1. Rittig S. Disorders of vasopressin and water metabolism. Handbook of Clinical Neurology. 2019;164:353-371. doi: 10.1016/B978-0-444-63855-7.00030-2
2. Robertson GL. Physiology of antidiuretic hormone. Am J Med. 1982;72(3):496-507. doi: 10.1016/0002-9343(82)90495-1
3. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol. 1997;272(5 Pt 2):F3-12. doi: 10.1152/ajprenal.1997.272.5.F3
4. Robertson GL. Vasopressin in the regulation of water balance. Kidney Int. 1984;25(4):689695. doi: 10.1038/ki.1984.62
5. Young WS, III. The molecular basis of vasopressin and oxytocin receptors in the central nervous system. Recent Prog Horm Res. 1991;47:245-272.
6. Veinante P, Freund-Mercier MJ. Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J Comp Neurol. 1997;383(3):305-325. doi: 10.1002/(sici)1096-9861(19970728)383:3<305::aid-cne2>3.0.co;2-c
7. Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev. 1996;20(3):341-358. doi: 10.1016/0149-7634(95)00051-6
8. Al-Damluji S, Hetta H, Bell C, Abraham WT. Vasopressin and vasodilatory shock. J Intensive Care Med. 2020;35(10):1119-1127. doi: 10.1177/0885066618824932
9. Griebel G, Perrault G, Simiand J, et al. SL 651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther. 2001;298(3):753-768.
10. Land H, Schutz G, Schmale H, Richter D, Noda M, Brinck U. A pro-vasopressin gene expressed in the hypothalamus of the human brain. Nature. 1983;306(5940):34-38. doi: 10.1038/306034a0
11. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42. doi: 10.1016/j.amjmed.2013.07.006
12. R W Schrier, J P Goldberg The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders Yale J Biol Med . 1980 NovDec;53(6):525-41.
13. Zaid Abassi 1 2 , Emad E Khoury 1 , Tony Karram 3 , Doron Aronson 4 Edema formation in congestive heart failure and the underlying mechanisms Front Cardiovas Med 2022 Sep 27;9:933215.
14. Sofia Jönsson 1 , Mediha Becirovic Agic 1 , Fredrik Narfström 2 , Jacqueline M Melville 1 , Michael Hultström 3 Renal neurohormonal regulation in heart failure decompensation Amer Journal Physiol Regul Integr Compar Physiol 2014 Sep 1;307(5):R493-7.
15. Dibya L Praharaj 1 , Anil C Anand 1 Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis J Clin Exp Hepatol 2022 Mar-Apr;12(2):575-594. doi: 10.1016/j.jceh.2021.09.008. Epub 2021 Sep 16.
16. Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24(3):549-572.
17. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2019;90(1):23-30.
18. Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: Epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281-293.
19. Fenske W, Quinkler M, Lorenz D, et al. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab. 2011;96(5):1506-1515.
20. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-2072.
21. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1-21.
22. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23(4):529-542.
23. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008;19(2):194-196.
24. Horacio J Adrogué 1 2 , Bryan M Tucker 1 2 , Nicolaos E Madias 34 Diagnosis and Management of Hyponatremia: A Review JAMA. 2022 Jul 19;328(3):280-291. doi: 10.1001/jama.2022.11176.
25. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008;3(4):1175-1184.
26. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349(9047):245-249.
27. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010;162 Suppl 1:S5-S12.
28. Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016;12(3):168-176. doi: 10.1038/nrendo.2015.221
29. Thompson CJ. Polydipsia. Eur J Endocrinol. 2010;163(6):819-827. doi: 10.1530/EJE-100442
30. Aronson R, Offman HJ, Joffe BI, et al. Psychogenic polydipsia: the result of a misdirected thirst. Q J Med. 1994;87(12):705-711.
31. Kline GA, Buse MG. Salt Wasting. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279012/
32. Szerlip HM, Yu ASL. Hyponatremia and hypernatremia. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 117.
33. Sterns RH. Disorders of plasma sodium - causes, consequences, and correction. N Engl J Med. 2015;372(1):55-65.
34. Bockenhauer D, Sinha MD. Bartter syndrome and Gitelman syndrome. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, eds. Pediatric Nephrology. 7th ed. Springer; 2016:1225-1255.
35. Kahali D, Sharma S, Das S. Evaluation of genetic causes in congenital adrenal hyperplasia: Personalized medicine approach. Clin Chim Acta. 2021;520:156-164.
36. Cabezuelo JB, Riancho-Zarrabeitia L, Lamas C, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med. 2018;52:11-16. 37. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-381.
38. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33-44.
39. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med. 1988;319(7):413-420.
40. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry. 1982;140:292-304.
41. Bagley SL, Weaver CA. Antidiuretic hormone (vasopressin) effects on blood pressure regulation. Compr Physiol. 2014;4(1):191-214.
42. Sharkey J, Solberg L, Lucke J. Norepinephrine-induced antidiuresis and antinatriuresis in human subjects. Life Sci. 1992;50(10):753-759.
43. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004;10(4):201-222.
44. Kalsbeek A, Fliers E. Daily regulation of hormone profiles. Handb Clin Neurol. 2019;160:223-241.
45. Bosch OJ, Neumann ID. Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci U S A. 2010;107(17):E1441-1442.
46. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42.e1.\
47. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51(1-2):23-47.
48. Baribeau D.A., Anagnostou E. Oxytocin and vasopressin: Linking pituitary neuropeptides and their receptors to social neurocircuits. Front. Neurosci. 2015;9:335. doi: 10.3389/fnins.2015.00335
49. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 17: 356: 2064-72.
50. Shepshelovich D, Leibovitch C, Klein A, Zoldan S, Milo G, Shochat T, Rozen-zvi B, Gafter-Gvili A, Lahav M. The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies. Eur J Intern Med 2015; 26: 819-24.
51. Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, EgbertsTC. Antipsychoticinduced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010; 33: 101-14.
52. Michael Dick,1 Sarah R Catford, 2 Kavita Kumareswaran,2,3 Peter Shane Hamblin,2,3 and Duncan J Topliss2,3 Persistent syndrome of inappropriate antidiuretic hormone secretion following traumatic brain injury Endocrinol Diabetes Metab Case Rep. 2015; 2015: 150070.
53. Mumtaz O Sanni 1 , Jeyanthy Rajkanna 2 , Satyanarayana V Sagi 3 , Samson O Oyibo 2 Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Complicated by Generalized Tonic-Clonic Seizures After a Course of Antibiotics: A Case Report Cureus. 2023 Apr 15;15(4):e37607. doi: 10.7759/cureus.37607.
54. Gheun-Ho Kim 1 Pathophysiology of Drug-Induced Hyponatremia J Clin med. 2022 Sep 30;11(19):5810. doi: 10.3390/jcm11195810.
55. Cassidy Vuong, Stan H. M. Van Uum, Laura E. O'Dell, Kabirullah Lutfy, and Theodore C. Friedman The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems Endocr Rev. 2010 Feb; 31(1): 98–132. Published online 2009 Nov 10. doi: 10.1210/er.2009-0009
56. Rimoy GH, Bhaskar NK, Wright DM, Rubin PC 1991 Mechanism of diuretic action of spiradoline (U-62066E)–a κ-opioid receptor agonist in the human. Br J Clin Pharmacol 32:611–615
57. Saadet Inan Kappa Opioid Agonist-Induced Diuresis: Characteristics, Mechanisms, and Beyond. Handbook of Experimental Pharmacology
58. A Grossman Brain opiates and neuroendocrine function Clinic Endocrinol Metab1983 Nov;12(3):725-46. doi: 10.1016/s0300-595x(83)80062-0.
59. A M Korinek, M Languille, F Bonnet, M Thibonnier, P Sasano, A Lienhart, P Viars Effect of postoperative extradural morphine on ADH secretion Br J Anaesth . 1985 Apr;57(4):407-11. doi: 10.1093/bja/57.4.407.
60. Feldberg W, Guertzenstein PG, Rocha e Silva M Jr. Vasopressin release by nicotine: The site of action. Br J Pharmacol 1975; 54: 463–474.
61. Christopher K Finch 1 , Miranda R Andrus, William A Curry Nicotine replacement therapy-associated syndrome of inappropriate antidiuretic hormone South Med J 2004 Mar;97(3):3224. doi: 10.1097/01.SMJ.0000082007.09497.5A.
62. J J Legros, B Conte-Devolx, G Rougon-Rapuzzi, Y Millet, P Franchimont [Simultaneous liberation of vasopressin (ADH) and of neurophysins during nicotine perfusion in man] . C R Ceanses Soc Biol Fil 1977;171(2):478-83.
2. Robertson GL. Physiology of antidiuretic hormone. Am J Med. 1982;72(3):496-507. doi: 10.1016/0002-9343(82)90495-1
3. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol. 1997;272(5 Pt 2):F3-12. doi: 10.1152/ajprenal.1997.272.5.F3
4. Robertson GL. Vasopressin in the regulation of water balance. Kidney Int. 1984;25(4):689695. doi: 10.1038/ki.1984.62
5. Young WS, III. The molecular basis of vasopressin and oxytocin receptors in the central nervous system. Recent Prog Horm Res. 1991;47:245-272.
6. Veinante P, Freund-Mercier MJ. Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J Comp Neurol. 1997;383(3):305-325. doi: 10.1002/(sici)1096-9861(19970728)383:3<305::aid-cne2>3.0.co;2-c
7. Engelmann M, Wotjak CT, Neumann I, Ludwig M, Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev. 1996;20(3):341-358. doi: 10.1016/0149-7634(95)00051-6
8. Al-Damluji S, Hetta H, Bell C, Abraham WT. Vasopressin and vasodilatory shock. J Intensive Care Med. 2020;35(10):1119-1127. doi: 10.1177/0885066618824932
9. Griebel G, Perrault G, Simiand J, et al. SL 651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther. 2001;298(3):753-768.
10. Land H, Schutz G, Schmale H, Richter D, Noda M, Brinck U. A pro-vasopressin gene expressed in the hypothalamus of the human brain. Nature. 1983;306(5940):34-38. doi: 10.1038/306034a0
11. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42. doi: 10.1016/j.amjmed.2013.07.006
12. R W Schrier, J P Goldberg The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders Yale J Biol Med . 1980 NovDec;53(6):525-41.
13. Zaid Abassi 1 2 , Emad E Khoury 1 , Tony Karram 3 , Doron Aronson 4 Edema formation in congestive heart failure and the underlying mechanisms Front Cardiovas Med 2022 Sep 27;9:933215.
14. Sofia Jönsson 1 , Mediha Becirovic Agic 1 , Fredrik Narfström 2 , Jacqueline M Melville 1 , Michael Hultström 3 Renal neurohormonal regulation in heart failure decompensation Amer Journal Physiol Regul Integr Compar Physiol 2014 Sep 1;307(5):R493-7.
15. Dibya L Praharaj 1 , Anil C Anand 1 Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis J Clin Exp Hepatol 2022 Mar-Apr;12(2):575-594. doi: 10.1016/j.jceh.2021.09.008. Epub 2021 Sep 16.
16. Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24(3):549-572.
17. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2019;90(1):23-30.
18. Sharma ST, Nieman LK, Feelders RA. Cushing's syndrome: Epidemiology and developments in disease management. Clin Epidemiol. 2015;7:281-293.
19. Fenske W, Quinkler M, Lorenz D, et al. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab. 2011;96(5):1506-1515.
20. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064-2072.
21. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1-21.
22. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23(4):529-542.
23. Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol. 2008;19(2):194-196.
24. Horacio J Adrogué 1 2 , Bryan M Tucker 1 2 , Nicolaos E Madias 34 Diagnosis and Management of Hyponatremia: A Review JAMA. 2022 Jul 19;328(3):280-291. doi: 10.1001/jama.2022.11176.
25. Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2008;3(4):1175-1184.
26. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349(9047):245-249.
27. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol. 2010;162 Suppl 1:S5-S12.
28. Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016;12(3):168-176. doi: 10.1038/nrendo.2015.221
29. Thompson CJ. Polydipsia. Eur J Endocrinol. 2010;163(6):819-827. doi: 10.1530/EJE-100442
30. Aronson R, Offman HJ, Joffe BI, et al. Psychogenic polydipsia: the result of a misdirected thirst. Q J Med. 1994;87(12):705-711.
31. Kline GA, Buse MG. Salt Wasting. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279012/
32. Szerlip HM, Yu ASL. Hyponatremia and hypernatremia. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 117.
33. Sterns RH. Disorders of plasma sodium - causes, consequences, and correction. N Engl J Med. 2015;372(1):55-65.
34. Bockenhauer D, Sinha MD. Bartter syndrome and Gitelman syndrome. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, eds. Pediatric Nephrology. 7th ed. Springer; 2016:1225-1255.
35. Kahali D, Sharma S, Das S. Evaluation of genetic causes in congenital adrenal hyperplasia: Personalized medicine approach. Clin Chim Acta. 2021;520:156-164.
36. Cabezuelo JB, Riancho-Zarrabeitia L, Lamas C, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med. 2018;52:11-16. 37. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-381.
38. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33-44.
39. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N Engl J Med. 1988;319(7):413-420.
40. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry. 1982;140:292-304.
41. Bagley SL, Weaver CA. Antidiuretic hormone (vasopressin) effects on blood pressure regulation. Compr Physiol. 2014;4(1):191-214.
42. Sharkey J, Solberg L, Lucke J. Norepinephrine-induced antidiuresis and antinatriuresis in human subjects. Life Sci. 1992;50(10):753-759.
43. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004;10(4):201-222.
44. Kalsbeek A, Fliers E. Daily regulation of hormone profiles. Handb Clin Neurol. 2019;160:223-241.
45. Bosch OJ, Neumann ID. Brain vasopressin is an important regulator of maternal behavior independent of dams' trait anxiety. Proc Natl Acad Sci U S A. 2010;107(17):E1441-1442.
46. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42.e1.\
47. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51(1-2):23-47.
48. Baribeau D.A., Anagnostou E. Oxytocin and vasopressin: Linking pituitary neuropeptides and their receptors to social neurocircuits. Front. Neurosci. 2015;9:335. doi: 10.3389/fnins.2015.00335
49. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 17: 356: 2064-72.
50. Shepshelovich D, Leibovitch C, Klein A, Zoldan S, Milo G, Shochat T, Rozen-zvi B, Gafter-Gvili A, Lahav M. The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies. Eur J Intern Med 2015; 26: 819-24.
51. Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, EgbertsTC. Antipsychoticinduced hyponatraemia: a systematic review of the published evidence. Drug Saf 2010; 33: 101-14.
52. Michael Dick,1 Sarah R Catford, 2 Kavita Kumareswaran,2,3 Peter Shane Hamblin,2,3 and Duncan J Topliss2,3 Persistent syndrome of inappropriate antidiuretic hormone secretion following traumatic brain injury Endocrinol Diabetes Metab Case Rep. 2015; 2015: 150070.
53. Mumtaz O Sanni 1 , Jeyanthy Rajkanna 2 , Satyanarayana V Sagi 3 , Samson O Oyibo 2 Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Complicated by Generalized Tonic-Clonic Seizures After a Course of Antibiotics: A Case Report Cureus. 2023 Apr 15;15(4):e37607. doi: 10.7759/cureus.37607.
54. Gheun-Ho Kim 1 Pathophysiology of Drug-Induced Hyponatremia J Clin med. 2022 Sep 30;11(19):5810. doi: 10.3390/jcm11195810.
55. Cassidy Vuong, Stan H. M. Van Uum, Laura E. O'Dell, Kabirullah Lutfy, and Theodore C. Friedman The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems Endocr Rev. 2010 Feb; 31(1): 98–132. Published online 2009 Nov 10. doi: 10.1210/er.2009-0009
56. Rimoy GH, Bhaskar NK, Wright DM, Rubin PC 1991 Mechanism of diuretic action of spiradoline (U-62066E)–a κ-opioid receptor agonist in the human. Br J Clin Pharmacol 32:611–615
57. Saadet Inan Kappa Opioid Agonist-Induced Diuresis: Characteristics, Mechanisms, and Beyond. Handbook of Experimental Pharmacology
58. A Grossman Brain opiates and neuroendocrine function Clinic Endocrinol Metab1983 Nov;12(3):725-46. doi: 10.1016/s0300-595x(83)80062-0.
59. A M Korinek, M Languille, F Bonnet, M Thibonnier, P Sasano, A Lienhart, P Viars Effect of postoperative extradural morphine on ADH secretion Br J Anaesth . 1985 Apr;57(4):407-11. doi: 10.1093/bja/57.4.407.
60. Feldberg W, Guertzenstein PG, Rocha e Silva M Jr. Vasopressin release by nicotine: The site of action. Br J Pharmacol 1975; 54: 463–474.
61. Christopher K Finch 1 , Miranda R Andrus, William A Curry Nicotine replacement therapy-associated syndrome of inappropriate antidiuretic hormone South Med J 2004 Mar;97(3):3224. doi: 10.1097/01.SMJ.0000082007.09497.5A.
62. J J Legros, B Conte-Devolx, G Rougon-Rapuzzi, Y Millet, P Franchimont [Simultaneous liberation of vasopressin (ADH) and of neurophysins during nicotine perfusion in man] . C R Ceanses Soc Biol Fil 1977;171(2):478-83.
Опубликован
2023-11-01
Как цитировать
Ангелова П., Руменов Калчев П. НАРУШЕНИЯ СЕКРЕЦИИ АНТИДИУРЕТИЧЕСКОГО ГОРМОНА // Здоровье человека, теория и методика физической культуры и спорта, 2023. Т. 31, № 3. С. 43-53. URL: http://hpcas.ru/article/view/13875.
Раздел
МЕДИКО-БИОЛОГИЧЕСКИЕ ПРОБЛЕМЫ ЗДОРОВЬЯ ЧЕЛОВЕКА
Copyright (c) 2023 Здоровье человека, теория и методика физической культуры и спорта
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 4.0 Всемирная.
Авторы, публикующиеся в этом журнале согласны со следующими условиями: авторы сохраняют свои авторские права и предоставляют журналу право первой публикации в связи с работой, которая одновременно распространяется по лицензии Creative Commons Attribution и позволяют другим иметь доступ к работе с признанием авторства этой работы и первоначальной публикацией в этом журнале. Авторы могут заключать отдельные, дополнительные договорные соглашения по неисключительному распространению опубликованной версии, с признанием ее первоначальной публикации в этом журнале.
Авторам разрешается и рекомендуется размещать их работу в Интернете (например, в институциональных хранилищах или на их сайте) до и во время процесса подачи, так как это может привести к продуктивным обменам, а также увеличению цитирования опубликованных работ (см. Политика открытого доступа)
Политика открытого доступа.
Заявление о конфиденциальности
Имена и адреса электронной почты, поданные при публикации в этом журнале, сайт будет использоваться исключительно для заявленных целей данного журнала, и они не будут доступны для любых других целей или какой-либо другой стороне.
Наша публикационная этика журнала основана, в значительной степени, на руководящих принципах и стандартах, разработанных Комитетом по этике публикации (COPE). Соответствующие обязанности и права авторов, рецензентов и редакторов журнала изложены ниже.
